SIN TY: Open Payments
NPI 1457783797 · POUGHKEEPSIE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,842 in 58 payments from 17 companies in 2025. Trend: 2023 $2,038 · 2024 $1,348 · 2025 $1,842
Food & beverage: $1,842
| Company | Payments | Amount |
|---|---|---|
| QOL Medical, LLC | 7 | $210 |
| Janssen Biotech, Inc. | 3 | $201 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $192 |
| Madrigal Pharmaceuticals | 4 | $185 |
| ABBVIE INC. | 9 | $153 |
| Ipsen Biopharmaceuticals, Inc | 1 | $150 |
| Aimmune Therapeutics, Inc. | 3 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $127 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Ardelyx, Inc. | 5 | $113 |
Products named: Sucraid, TREMFYA, REZDIFFRA, XIFAXAN, IQIRVO, ZENPEP, ENTYVIO, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
